Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Psychopharmacology

• Publication date

  2003-04-17

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-003-1452-8PMID 12700882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The medical emergency team, evidence‐based medicine and ethics

  2003cited by this paper
• Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion.

  2002cited by this paper
• Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity.

  2002cited by this paper
• Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat

  2002cited by this paper
• Assessing antidepressant activity in rodents: recent developments and future needs.

  2002influential reference
• Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")

  2002cited by this paper
• A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field

  2002cited by this paper
• On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA

  2002cited by this paper
• Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat.

  2002cited by this paper
• Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine.

  2002cited by this paper
• Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

  2001cited by this paper
• Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA ("ecstasy")-induced neurodegeneration in rat brain

  2001cited by this paper
• Phenobarbital and dizocilpine can block methamphetamine-induced neurotoxicity in mice by mechanisms that are independent of thermoregulation.

  2001cited by this paper
• Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats.

  2001cited by this paper
• Long‐term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine

  2001cited by this paper
• Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy").

  2001cited by this paper
• Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.

  2001cited by this paper
• Potential Human Neurotoxicity of MDMA (‘Ecstasy’): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies

  2000cited by this paper
• Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans

  2000cited by this paper
• MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks.

  2000cited by this paper
• Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

  2000cited by this paper
• Ecstasy (MDMA): a review of its possible persistent psychological effects

  2000cited by this paper
• Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat

  1999influential reference
• Ecstasy use in Australia: patterns of use and associated harm.

  1999cited by this paper
• In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism.

  1999cited by this paper
• Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat

  1998influential reference
• Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

  1998cited by this paper
• The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

  1998cited by this paper
• MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

  1998cited by this paper
• Role of hyperthermia in the protective action of clomethiazole against MDMA (‘ecstasy’)‐induced neurodegeneration, comparison with the novel NMDA channel blocker AR‐R15896AR

  1998cited by this paper
• MDMA induced hyperthermia: a survivor with an initial body temperature of 42.9 degrees C.

  1997cited by this paper
• Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles.

  1997cited by this paper
• Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.

  1996cited by this paper
• Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.

  1995cited by this paper
• The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

  1995cited by this paper
• Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response.

  1995influential reference
• Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")

  1995cited by this paper
• Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”)

  1995cited by this paper
• Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.

  1995cited by this paper
• Further studies of the role of hyperthermia in methamphetamine neurotoxicity.

  1994cited by this paper
• Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”) in rats

  1994influential reference
• Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.

  1993influential reference
• 5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine

  1993cited by this paper
• The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.

  1992cited by this paper
• Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

  1992cited by this paper
• Ecstasy, 3–4 Methylenedioxymethamphetamine (MDMA), a Fatality Associated with Coagulopathy and Hyperthermia

  1991cited by this paper
• Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat.

  1991influential reference
• Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.

  1990influential reference
• 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.

  1987cited by this paper
• Cholinergic modulation of the release of 5-hydroxytryptamine from the guinea pig ileum

  1987cited by this paper
• Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

  1985cited by this paper

• Methylphenidate and Its Impact on Redox Balance and Behavior

  2025cites this paper
• The relationship between 3,4‐methylenedioxymethamphetamine (MDMA) use in young adulthood and anxiety or depressive disorders in the mid‐30s: Findings from the Victorian Adolescent Health Cohort Study

  2025cites this paper
• Repeated administration of N-ethyl-pentedrone induces increased aggression and impairs social exploration after withdrawal in mice.

  2022cites this paper
• MDMA and memory, addiction, and depression: dose-effect analysis

  2022cites this paper
• Behavioural and neurochemical effects after repeated administration of N‐ethylpentylone (ephylone) in mice

  2021cites this paper
• A Systematic Review of the MDMA Model to Address Social Impairment in Autism

  2021influential citation
• Title Cognitive Effects of MDMA in Laboratory Animals : A Systematic Review Focusing on Dose Permalink

  2019cites this paper
• Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose

  2019cites this paper
• Bio-behavioural evaluation of efavirenz and Δ9-tetrahydrocannabinol alone and in combination in rats with respect to psychosis and anxiety

  2019cites this paper
• Chronic stress causes protein kinase C epsilon-aldehyde dehydrogenase 2 signaling pathway perturbation in the rat hippocampus and prefrontal cortex, but not in the myocardium

  2018cites this paper
• What is the role of subcutaneous single injections on the behavior of adult male rats exposed to drugs?

  2018cites this paper
• Differential effects of MDMA and cocaine on inhibitory avoidance and object recognition tests in rodents

  2017cites this paper
• The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior.

  2017cites this paper
• The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish

  2017cites this paper
• The long-term effects of methamphetamine exposure during pre-adolescence on depressive-like behaviour in a genetic animal model of depression

  2016cites this paper
• Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress.

  2016cites this paper
• The behavioural implications of postnatal exposure to benzylpiperazhie and methamphetamine - a longitudinal doserelated study in male and female rats.

  2015cites this paper
• o the effects of prenatal exposure and acute treatment of ethamphetamine on anxiety vary depending on the animal model sed ?

  2015cites this paper
• Neuropharmacology and toxicology of novel amphetamine-type stimulants

  2015cites this paper
• Effect of drugs of abuse on social behaviour: a review of animal models

  2015cites this paper
• Do the effects of prenatal exposure and acute treatment of methamphetamine on anxiety vary depending on the animal model used?

  2015cites this paper
• Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse

  2015cites this paper
• Effects of psychostimulants on social interaction in adult male rats

  2015cites this paper
• Dose and Time-Dependent Selective Neurotoxicity Induced by Mephedrone in Mice

  2014cites this paper
• Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone

  2014cites this paper
• The long-term effects of methamphetamine on depressive-like behaviour and neuroplasticity in stress-sensitive rats

  2014cites this paper
• Nuevas drogas psicoestimulantes. Estudio farmacológico y neurotoxicológico de la metilona

  2014cites this paper
• Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse

  2014cites this paper
• Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats.

  2013influential citation
• 3,4-Methylenedioxymethamphetamine Induces Gene Expression Changes in Rats Related to Serotonergic and Dopaminergic Systems, But Not to Neurotoxicity

  2013cites this paper
• Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone.

  2013cites this paper
• Drug withdrawal-induced depression: serotonergic and plasticity changes in animal models.

  2012cites this paper
• Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT Depletion

  2012cites this paper
• (±)3,4‐methylenedioxymethamphetamine (“ecstasy”) treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain

  2012cites this paper
• Behavioural and Neurochemical Consequences of MDMA Self-Administration in Rats

  2012cites this paper
• EFFECT OF MEDIUM-TERM INJECTION OF MDMA ON THE ANXIETY OF MALE RAT WITH PLUS MAZE TEST

  2012cites this paper
• Withdrawal from chronic, intermittent access to a highly palatable food induces depressive-like behavior in compulsive eating rats

  2012cites this paper
• Glutamate and MDMA Neurobehavioral Toxicity

  2012cites this paper
• Behavioral assessment of depressive-like symptoms in a rodent model of spinal cord injury

  2011cites this paper
• Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats

  2011cites this paper
• Neuroadaptive Changes in  5-HT1A Autoreceptor Sensitivity  Following High-Dose MDMA Treatment

  2011cites this paper
• Implication du système endocannabinoïde dans la dépendance à la nicotine

  2011cites this paper
• Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats

  2010cites this paper
• A long hangover from party drugs: residual proteomic changes in the hippocampus of rats 8 weeks after γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.

  2010cites this paper
• Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination

  2010influential citation
• The health and psychological effects of "ecstasy" (MDMA) use

  2010cites this paper
• Mice in ecstasy: advanced animal models in the study of MDMA.

  2010cites this paper
• A Cannabinoid CB1 Receptor Antagonist Ameliorates Impairment of Recognition Memory on Withdrawal from MDMA (Ecstasy)

  2010cites this paper
• Current pharmacological models of social withdrawal in rats: relevance to schizophrenia

  2010cites this paper
• Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines

  2009cites this paper
• Neural and Behavioural Effects of the Ginkgo biloba Leaf Extract Egb 761

  2009cites this paper
• Weekly γ-Hydroxybutyrate Exposure Sensitizes Locomotor Hyperactivity to Low-Dose 3,4-Methylenedioxymethamphetamine in Rats

  2009cites this paper
• Efectos conductuales y neuroquímicos del consumo de éxtasis y cocaína en ratones adolescentes.

  2009cites this paper
• Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.

  2009cites this paper
• The role of serotonin in brain development and 3,4- methylenedioxymethamphetamine-induced cognitive deficits

  2009cites this paper
• From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long‐term adverse consequences of drug use?

  2008cites this paper
• Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.

  2008cites this paper
• Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats.

  2008cites this paper
• Dissociation of the Neurochemical and Behavioral Toxicology of MDMA (‘Ecstasy’) by Citalopram

  2008cites this paper
• Developmental effects of 3,4-methylenedioxymethamphetamine: a review

  2008cites this paper
• (+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks.

  2008cites this paper
• Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: role of individual differences in anxiety-related behavior.

  2008cites this paper
• High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")-induced Fos expression in a region-specific manner.

  2007cites this paper
• Ethanol–MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination

  2007cites this paper
• International conference on memory (ICOM-4), University of New South Wales, Sydney, Australia, 16—21 July 2006 Ecstasy/MDMA and Memory Symposium

  2007cites this paper
• A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

  2007cites this paper
• MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.

  2007cites this paper
• Emergency Management of Drug Abuse

  2007cites this paper
• Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats.

  2007cites this paper
• The rostral anterior cingulate cortex modulates depression but not anxiety-related behaviour in the rat.

  2006cites this paper
• Treatment of adolescent rats with 1-benzylpiperazine: a preliminary study of subsequent behavioral effects.

  2006cites this paper
• Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test.

  2006cites this paper
• MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress

  2006cites this paper
• Exposure to benzylpiperazine (BZP) in adolescent rats: Adulthood

  2006cites this paper
• Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

  2006cites this paper
• Treatment Implications for Young Adult Users of MDMA

  2006cites this paper
• Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats.

  2006influential citation
• 3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory.

  2006cites this paper
• Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats

  2006cites this paper
• Repeated Adolescent 3,4-Methylenedioxymethamphetamine (MDMA) Exposure in Rats Attenuates the Effects of a Subsequent Challenge with MDMA or a 5-Hydroxytryptamine1A Receptor Agonist

  2006cites this paper
• Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis

  2005cites this paper
• Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding.

  2005influential citation
• Chronic repetitive transcranial magnetic stimulation is antidepressant but not anxiolytic in rat models of anxiety and depression.

  2005cites this paper
• Psychostimulant withdrawal as an inducing condition in animal models of depression.

  2005cites this paper
• Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.

  2005cites this paper
• MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.

  2005cites this paper
• Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats.

  2004influential citation
• MDMA (3,4-Methylenedioxymethamphetamine) or Ecstasy: The Neuropsychobiological Implications of Taking It at Dances and Raves

  2004cites this paper
• The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test.

  2004cites this paper
• Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.

  2004cites this paper
• Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period.

  2004cites this paper
• Potentiation of (DL)‐3,4‐methylenedioxymethamphetamine (MDMA)‐induced toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist MDL 11,939

  2004cites this paper
• MDMA (“ecstasy”), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat

  2004influential citation
• Chronic Fluoxetine Treatment Partly Attenuates the Long-Term Anxiety and Depressive Symptoms Induced by MDMA (‘Ecstasy’) in Rats

  2004cites this paper
• Neurotoxic effects of MDMA (“ecstasy”) administration to neonatal rats

  2004cites this paper
• Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine

  2003cites this paper
• Maps' Mdma Investigator's Brochure Update #1 a Review of Research in Humans and Non-human Animals

  2003influential citation
• Dissociation of the Neurochemical and Behavioral Toxicology of Mdma ('ecstasy') by Citalopram

  year unknowncites this paper